I am optimistic after that discussion that they are raising funds I think at least $.85 or higher. in the new year.  I was in this back at the beginning and made money however didn't ride it to $25.92 in 2007. Getting some of these advisors on board in US may turn some heads for Big Pharma's and not sure how accurate it is but the dual purpose aspect if correct may give them a distinct advantage for Apabetalone, particularly if it keeps patients out of hospital and helps with long covid. DM did seem to eat some humble pie which is good we are all human. It seems having Eversana on board is paying off.